Comparison of Single-Agent Versus 3-Additive Regional Anesthesia for Foot and Ankle Surgery

被引:5
|
作者
Dang, Debbie Y. [1 ]
McGarry, Sean M. [2 ]
Melbihess, Eric J. [3 ]
Haytmanek, Craig T. [4 ]
Stith, Andrew T. [5 ]
Griffin, Matthew J. [6 ]
Ackerman, Katherine J. [7 ]
Hirose, Christopher B. [1 ]
机构
[1] Coughlin Clin, St Alphonsus Reg Med Ctr, 1075 N Curtis Rd Suite 300, Boise, ID 83706 USA
[2] Oregon Anesthesia Grp Pc, Portland, OR USA
[3] Boise Anesthesia, Boise, ID USA
[4] Steadman Clin, Vail, CO USA
[5] Wyoming Orthopaed & Sports Med, Cheyenne, WY USA
[6] Synergy Orthopaed Specialists Med Grp, San Diego, CA USA
[7] Pacific Northwest Univ Hlth Sci, Yakima, WA USA
关键词
peripheral nerve block; regional anesthesia; multimodal anesthesia; bupivacaine; buprenorphine; clonidine; dexamethasone; PERIPHERAL-NERVE BLOCKS; POSTOPERATIVE PAIN; POPLITEAL BLOCK; OUTPATIENT FOOT; MULTIMODAL ANALGESIA; GENERAL-ANESTHESIA; GERIATRIC-PATIENTS; SAPHENOUS NERVE; COMPLICATIONS; RISK;
D O I
10.1177/1071100719859020
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: This study compared the results of regional blocks containing a single anesthetic, bupivacaine, with those containing bupivacaine and 3 additives (buprenorphine, clonidine, and dexamethasone) in patients undergoing foot and ankle surgery. Methods: Eighty patients undergoing foot and ankle surgery over a 9-month period were prospectively enrolled and randomized to receive a peripheral nerve block containing either a single anesthetic (SA) or one with 3 additives (TA). Patients, surgeons, and anesthesiologists were blinded to the groups. Patients maintained pain diaries and were evaluated at 1 and 12 weeks postoperatively. Fifty-six patients completed the study. Results: The TA group had a longer duration of analgesic effect than the SA group (average 82 vs 34 hours, P < .05). Forty-eight hours after surgery, 93% of SA blocks, compared with 34% of TA blocks, had completely worn off. The TA group had a longer duration of sensory effects. At 3 months, 10 of 26 (38.5%) TA patients, compared with 3 of 30 (10%) SA patients, reported postoperative neurologic symptoms. Pain scores in both groups were not statistically different at 1 week or 3 months after surgery. Patients in both groups were similarly satisfied with their blocks. Conclusion: Both types of nerve blocks provided equivalent pain control and patient satisfaction in patients undergoing foot and ankle surgery. The 3-additive agent blocks were associated with a longer duration of pain relief and a longer duration of numbness, as well as higher rates of postoperative neurologic symptoms. Longer pain relief may be obtained at the cost of prolonged sensory deficits.
引用
收藏
页码:1195 / 1202
页数:8
相关论文
共 50 条
  • [41] A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Tedeschi, Alessandra
    Greil, Richard
    Demirkan, Fatih
    Robak, Tadeusz
    Moreno, Carol
    Barr, Paul M.
    Anz, Bertrand
    Simpson, David
    Gaidano, Gianluca
    Bairey, Osnat
    Stevens, Don
    Gill, Devinder
    Flinn, Ian W.
    Kipps, Thomas J.
    Burger, Jan A.
    Lin, Jennifer
    Webb, Thomas
    Fedorov, Viktor
    Styles, Lori
    Gribben, John G.
    HAEMATOLOGICA, 2020, 105 (04)
  • [42] The efficacy and safety of continuous versus single-injection popliteal sciatic nerve block in outpatient foot and ankle surgery: a systematic review and meta-analysis
    Ma, Hsuan-Hsiao
    Chou, Te-Feng Arthur
    Tsai, Shang-Wen
    Chen, Cheng-Fong
    Wu, Po-Kuei
    Chen, Wei-Ming
    BMC MUSCULOSKELETAL DISORDERS, 2019, 20 (01)
  • [43] The efficacy and safety of continuous versus single-injection popliteal sciatic nerve block in outpatient foot and ankle surgery: a systematic review and meta-analysis
    Hsuan-Hsiao Ma
    Te-Feng Arthur Chou
    Shang-Wen Tsai
    Cheng-Fong Chen
    Po-Kuei Wu
    Wei-Ming Chen
    BMC Musculoskeletal Disorders, 20
  • [44] Comparison of Postoperative Outcome in Children Undergoing Inguinal Hernia Repair Using Regional With General Versus General Anesthesia Alone: A Single Center Study
    Kabbani, Omar M.
    Alhabdan, Khaled A.
    Almahbub, Abdulaziz Y.
    Kabbani, Nasib M.
    Ardah, Husam I.
    Mahmoud, Ahmed Haroun M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [45] Improvement of the Chemoradiotherapy Followed by Surgery for Advanced Pancreatic Ductal Adenocarcinoma: Comparison of the Histopathological Effect Between Single-Agent Gemcitabine and S-1/Gemcitabine Combination Therapy
    Kishiwada, M.
    Kato, H.
    Murata, Y.
    Tanemura, A.
    Kuriyama, N.
    Azumi, Y.
    Mizuno, S.
    Usui, M.
    Ssakurai, H.
    Isaji, S.
    PANCREAS, 2014, 43 (08) : 1380 - 1380
  • [46] A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery
    Pu, Juan
    Qin, Shan-shan
    Ding, Jin-xia
    Zhang, Yan
    Zhu, Wei-guo
    Yu, Chang-hua
    Li, Tao
    Tao, Guang-zhou
    Ji, Fu-zhi
    Zhou, Xi-lei
    Han, Ji-hua
    Ji, Ya-lin
    Sun, Jun-xia
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (04) : 703 - 708
  • [47] A randomized controlled study of single-agent cisplatin and radiotherapy versus docetaxel/cisplatin and radiotherapy in high-risk early-stage cervical cancer after radical surgery
    Juan Pu
    Shan-shan Qin
    Jin-xia Ding
    Yan Zhang
    Wei-guo Zhu
    Chang-hua Yu
    Tao Li
    Guang-zhou Tao
    Fu-zhi Ji
    Xi-lei Zhou
    Ji-hua Han
    Ya-lin Ji
    Jun-xia Sun
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 703 - 708
  • [48] Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies
    Kovac, Anthony L.
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 873 - 887
  • [49] Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial
    Parmar, MKB
    Adams, M
    Balestrino, M
    Bertelsen, K
    Bonazzi, C
    Calvert, H
    Colombo, N
    Delaloye, JF
    Durando, A
    Guthrie, D
    Hagen, B
    Harper, P
    Mangioni, C
    Perren, T
    Poole, C
    Qian, W
    Rustin, G
    Sandercock, J
    Tumolo, S
    Torri, V
    Vecchione, F
    LANCET, 2002, 360 (9332): : 505 - 515
  • [50] Single-Agent Ibrutinib Versus Real-World Treatments for Patients with Treatment-Naive Chronic Lymphocytic Leukemia: Adjusted Comparison of Resonate-2™ with Real-World Databases
    Salles, Gilles
    Smolej, Lukas
    Bachy, Emmanuel
    Baseggio, Lucile
    Besson, Herve
    Hermans, Ruben
    Healy, Nollaig
    Garside, Jamie
    Iraqi, Wafae
    Diels, Joris
    MacDougall, Finlay
    Pick-Lauer, Corinna
    Spacek, Martin
    Urbanova, Renata
    Lysak, Daniel
    Callet-Bauchu, Evelyne
    Doubek, Michael
    BLOOD, 2017, 130